Successful 40-Hz auditory stimulation in aged monkeys suggests potential for noninvasive Alzheimer’s therapy

A research team from the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has demonstrated for the first time in non-human primates that auditory stimulation at 40 Hz significantly elevates β-amyloid levels in the cerebrospinal fluid (CSF) of aged rhesus monkeys, with this effect persisting for over five weeks.

The study, published in the Proceedings of the National Academy of Sciences on January 5, provides the first non-human primate experimental evidence supporting the use of 40-Hz stimulation as a noninvasive physical therapy for Alzheimer’s disease (AD), revealing significant differences between primate and rodent models.

Study design and key findings

Researchers led by Dr. Hu Xintian at KIZ, together with collaborators, conducted the study using nine aged rhesus macaques (Macaca mulatta) aged 26–31 years. These aged individuals developed widespread spontaneous amyloid plaques in their brains, effectively mimicking the Aβ pathological feature of human AD and making them an ideal translational research model.

Sign up for Blog Updates